Literature DB >> 36262483

A Case of COVID-19 Induced Descending Aortic Thrombus and Splenic Infarctions.

Srikrishna V Malayala1, Syed Bukhari1, Rachana Vanaparthy2, Ambreen Raza3, Ramya Akella4.   

Abstract

Thromboembolic manifestations like pulmonary embolism and deep venous thrombosis are often reported and contribute to a significant mortality from acute and chronic COVID-19 infections. These phenomena are a result of the activation of the coagulation cascade by the COVID-19 induced inflammatory state. Majority of the thrombotic incidences are reported as a venous thrombosis but extremely rarely, arterial thrombi can be a manifestation of acute COVID-19 infection. The patient in our case report was an unvaccinated 47-year-old female who presented with fever, nausea, abdominal pain and vomiting. The imaging confirmed the presence of a non-occlusive thrombus in the descending aorta, multiple splenic infarctions and paralytic ileus. She was treated with systemic anti-coagulation. A hyper-coagulable workup was performed on the patient and no other risk factors that could contribute to a thrombus was identified.
© 2022 Greater Baltimore Medical Center.

Entities:  

Keywords:  Aortic thrombus; Covid-19; Ileus; Splenic infarction

Year:  2022        PMID: 36262483      PMCID: PMC9529656          DOI: 10.55729/2000-9666.1100

Source DB:  PubMed          Journal:  J Community Hosp Intern Med Perspect        ISSN: 2000-9666


  20 in total

1.  A case series of vestibular symptoms in positive or suspected COVID-19 patients.

Authors:  Srikrishna Varun Malayala; Gisha Mohan; Deepa Vasireddy; Paavani Atluri
Journal:  Infez Med       Date:  2021-03-01

2.  Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms.

Authors:  Renuka Ananth Kalyan Kadali; Ravali Janagama; Sharanya Peruru; Viswanath Gajula; Rajasekhar R Madathala; Nikhita Chennaiahgari; Srikrishna V Malayala
Journal:  J Med Virol       Date:  2021-05-05       Impact factor: 2.327

3.  Coagulation abnormalities and thrombosis in patients with COVID-19.

Authors:  Marcel Levi; Jecko Thachil; Toshiaki Iba; Jerrold H Levy
Journal:  Lancet Haematol       Date:  2020-05-11       Impact factor: 18.959

4.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.

Authors:  Ning Tang; Dengju Li; Xiong Wang; Ziyong Sun
Journal:  J Thromb Haemost       Date:  2020-03-13       Impact factor: 5.824

5.  Purpuric Rash and Thrombocytopenia After the mRNA-1273 (Moderna) COVID-19 Vaccine.

Authors:  Srikrishna V Malayala; Gisha Mohan; Deepa Vasireddy; Paavani Atluri
Journal:  Cureus       Date:  2021-03-25

6.  Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers.

Authors:  Renuka A K Kadali; Ravali Janagama; Sharanya Peruru; Srikrishna V Malayala
Journal:  Int J Infect Dis       Date:  2021-04-15       Impact factor: 3.623

Review 7.  COVID-19 update: Covid-19-associated coagulopathy.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2020-07       Impact factor: 2.300

Review 8.  Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.

Authors:  Mahmoud Gheblawi; Kaiming Wang; Anissa Viveiros; Quynh Nguyen; Jiu-Chang Zhong; Anthony J Turner; Mohan K Raizada; Maria B Grant; Gavin Y Oudit
Journal:  Circ Res       Date:  2020-04-08       Impact factor: 17.367

9.  COVID-19 and its implications for thrombosis and anticoagulation.

Authors:  Jean M Connors; Jerrold H Levy
Journal:  Blood       Date:  2020-06-04       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.